Obesity interacts with cerebral hypoperfusion to exacerbate cognitive impairment in older adults with heart failure

Michael L Alosco1, Mary Beth Spitznagel, Naftali Raz

  • 1Department of Psychology, Kent State University, Kent, Ohio, USA.

Insights

Heart failure patients with both reduced cerebral blood flow and obesity experience worse attention and executive function. Weight reduction may benefit heart failure patients at risk for cognitive decline.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Heart failure (HF) is linked to reduced cerebral blood flow and cognitive impairment.
  • Obesity is common in HF patients and independently associated with cognitive decline.
  • The interplay between obesity, cerebral hypoperfusion, and cognition in HF requires further investigation.

Purpose of the Study:

  • To examine the association between obesity and cognitive performance in older adults with HF.
  • To determine if obesity exacerbates cognitive impairment in HF patients with cerebral hypoperfusion.

Main Methods:

  • Ninety-nine HF patients underwent neuropsychological testing and impedance cardiography.
  • Cerebral blood flow velocity (CBF-V) was measured using transcranial Doppler sonography.
  • Obesity was assessed using body mass index (BMI).

Main Results:

  • Lower CBF-V correlated with poorer performance in attention/executive function and memory.
  • Higher BMI was independently linked to reduced performance in attention/executive function and language.
  • A significant interaction showed that combined hypoperfusion and high BMI adversely affect attention/executive function.

Conclusions:

  • Cerebral hypoperfusion and obesity interact to impair cognitive function in HF patients.
  • These findings highlight the potential benefits of weight reduction for HF patients at risk of cognitive impairment.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...